version-1-1-1024x485-min

Consumers Who Have Used Zantac® And Been Diagnosed With Certain Cancers May Be Eligible For Justice and Substantial Compensation

Consumers Who Have Used Zantac® And Been Diagnosed With Certain Cancers May Be Eligible For Justice and Substantial Compensation

Consumers encouraged to seek out legal case evaluations for conditions such as…

  • Bladder Cancer
  • Small Intestine/Colorectal Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Esophageal Cancer
  • Liver Cancer
  • Gastric Cancer

FREE CLAIM REVIEW

Did you take any of the following Medications? (Check all that Apply)(Required)
To qualify, Please Check All that Apply(Required)
Name(Required)

By clicking the "SUBMIT" button, I consent to receive recurring auto dialed and/or text messages from Shield Legal LP, and Tort Intake Professionals LLC or our partners in order to discuss my legal options and at the telephone number I provided. I also consent to the Shield Legal LP Privacy Policy and Terms of Use. I understand that I may receive a call even if my telephone number is listed on a Do Not Call list and that my consent is not a requirement of purchase. I understand that my telephone company may impose charges on me for these contacts and that I can revoke this consent at any time. For SMS campaigns: Text STOP to cancel and HELP for help. Msg & data rates may apply. Recurring msgs up to 27 msgs per month.

100% confidential Case Evaluations

Answer a few basic questions to get started

Receive a confidential case evaluation

Have an individual claim filed for compensation

Here are the alleged dangers of Zantac® (aka ranitidine®) causing cancers

Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® beginning in 1983 to reduce excess acid produced in stomach cells.

Despite the fact that it was first approved for short-term use only by the Federal Drug Administration (FDA)--the reason being primarily for its potential to cause cancer if prescribed in long-term use–Zantac® began being marketed for long-term maintenance use.

Since over-the-counter Zantac® (aka ranitidine®) contains high levels of NDMA, it has potentially linked to several types of lifelong cancers, including:

  • Esophageal cancer. A cancer more common in men that can cause difficulty swallowing, chest pain, and heartburn–this may convince victims into taking more to reduce the symptoms.
  • Liver cancer. Patients diagnosed with liver cancer after taking Zantac® (aka ranitidine®) typically complain of abdominal pain, swelling in the abdomen and general loss of energy.
  • Stomach cancer. Also known as gastric cancer, this type of cancer forms over the course of many years–with a five-year survival rate for diagnosed individuals being 70%.

Pancreatic cancer. Because it’s often not diagnosed until the later stages, this is a particularly deadly form of cancer–with common symptoms that include itchy skin, yellowing of the eyes, and abdominal pain

CLICK HERE FOR A FREE LEGAL CASE REVIEW

Billions in profits made on unsafe Medication

Earlier reports and statistics highlight the dangers of conditions resulting from Zantac® (aka ranitidine®) use

Very Well Health reveals that since 1983, the FDA Adverse Event Reporting System (FAERS) has received a total of 73,240 cases with a negative effect of Zantac®.

This includes:

  • 55,891 serious cases
  • 4,926 deaths
  • 66% of cases were linked to cancer

18,739,686 people in the United States were prescribed Zantac® in 2018–1,094 cases involving Zantac® were reported to the FDA in the same year.

According to USA Today, a 2016 Stanford University research study indicated that urine samples of 10 people who took a 150-milligram tablet of Zantac® and found NDMA (a known carcinogen) levels far greater than the FDA's daily limits.

100% FREE CASE EVALUATION. SEE IF YOU QUALIFY TODAY!

CLICK HERE FOR A FREE LEGAL CASE REVIEW

Please seek the advice of a medical professional before making health care decisions. This advertisement is not associated with a Zantac®, Sanofi®, Zantac's® generic manufacturers, or any government agency.